DuPont de Nemours, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated September 10, 2026, reports on events occurring on September 9, 2026. DuPont de Nemours, Inc. (DuPont), along with The Chemours Company and Corteva Inc. (including EIDP, Inc.), entered into a Settlement Agreement with the State of North Carolina and various state subdivisions. The settlement resolves claims regarding PFAS and other emissions from the Fayetteville Works facility, as well as unrelated PFAS contamination involving aqueous film-forming foam (AFFF).
Key Financial Metrics and Settlement Terms
- Total Settlement Amount: $455 million in aggregate cash payments to Plaintiffs.
- Payment Term: Payable over 15 years.
- Cost Allocation: Payments are shared among DuPont, Chemours, and Corteva per a 2021 Memorandum of Understanding (MOU).
- Specific Liability Breakdown: $18 million is attributed to PFAS contamination unrelated to Fayetteville Works; no more than $14.4 million (approx. 3%) is ascribed to AFFF.
- Reserve Fund: DuPont and Corteva will establish a $135 million Reserve Fund as financial security, accessible only if Chemours fails to perform obligations under its 2019 Consent Order.
- Escrow Impact: Combined payments from this settlement and a 2025 New Jersey settlement exceed future escrow contribution obligations, satisfying all future MOU escrow contributions, including the September 2026 payment.
Material Changes and Prior Period Activity
In the second quarter of 2026, DuPont recorded a probable loss of approximately $125 million within discontinued operations. This amount reflects the pre-tax net present value of DuPont's share of the cash payment under the MOU, prior to accounting for a 44% reimbursement obligation from Qnity Electronics Inc. The filing notes that the settlement and potential future litigation settlements will be counted against the MOU limit at net present value, discounted at 8% over 25 years.
Guidance, Risks, and Contingencies
The Settlement Agreement is subject to the entry of orders dismissing the covered claims. The filing includes a cautionary statement regarding forward-looking statements, noting uncertainties related to:
- Final terms of cost-sharing arrangements.
- Outcomes of pending or future PFAS litigation, including personal injury and natural resource damage claims.
- Extent and cost of ongoing and future remediation obligations.
- Changes in laws and regulations applicable to PFAS chemicals.
- Performance of obligations by all parties under the cost-sharing arrangement.
Management states that material differences in results could lead to business disruption, financial loss, or legal liability.
Investor Verification Checklist
- Verify the exact share of the $455 million settlement attributable to DuPont after the 44% reimbursement from Qnity Electronics Inc.
- Confirm the impact of the $125 million Q2 2026 loss on discontinued operations and net income.
- Review the full text of the Settlement Agreement (Exhibit 10.1) for specific payment schedules and conditions.
- Assess the status of the $135 million Reserve Fund and the conditions triggering its use.
- Monitor future filings for updates on the dismissal of claims and the finalization of the settlement.